Background illustration for clinical trials search

Endocrine Clinical Trials

Browse 341 endocrine clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

for
Cervical Large Cell Neuroendocrine Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT04723095

Recruiting

Hypofractionated Radiation Therapy for Merkel Cell Carcinoma

for
Merkel Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05100095

Phase2, Recruiting

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

for
Growth Hormone Deficiency
Location: Manchester NH, Lebanon NH, New Hyde Park NY,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 1 - 18

Code: NCT05775523

Recruiting

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

for
Digestive System Neuroendocrine Tumor G1,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06016855

Recruiting

The Impact of Removal of Exercise on Glycemic Control and Vascular Health in Older Active Adults

for
Glucose Intolerance, Exercise, Vascular Function
Location: Norfolk VA
Sponsor: Old Dominion University

Sex: All

Age: 0+

Code: NCT05468255

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer

for
Prostate Cancer, Prostate Adenocarcinoma,
Location: Miami FL
Sponsor: University of Miami

Sex: Male

Age: 18+

Code: NCT06392295

Phase2, Recruiting

Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

for
Adult Growth Hormone Deficiency, Mild Traumatic Brain Injury
Location: Minneapolis MN, Houston TX, Seattle WA
Sponsor: VA Office of Research and Development

Sex: All

Age: 21 - 55

Code: NCT04867317

Phase3, Recruiting

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

for
Neuroendocrine Tumors, Colorectal Cancer, Gastric Cancer
Location: Philadelphia PA, Atlanta GA, Nashville TN, Chicago IL
Sponsor: Chimeric Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06055439

Phase1, Phase2, Recruiting

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Mineola NY, New York NY, Baltimore MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05896839

Phase1, Phase2, Recruiting

Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC

for
Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer,
Location: Miami FL, Atlanta GA, Fairway KS
Sponsor: Reshma L. Mahtani, D.O.

Sex: All

Age: 18+

Code: NCT06263543

Phase2, Recruiting

68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors

for
Neuroendocrine Tumors
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 0+

Code: NCT04888481

Phase2, Recruiting

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

for
Small Cell Lung Carcinoma, Neuroendocrine Neoplasms,
Location: The Bronx NY, Baltimore MD, Richmond VA, Miami FL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT05882058

Phase2, Recruiting

Regulation of Endogenous Glucose Production by Central KATP Channels

for
Diabetes Mellitus, Glucose Metabolism Disorders
Location: The Bronx NY
Sponsor: Albert Einstein College of Medicine

Sex: All

Age: 21 - 70

Code: NCT03540758

Phase2, Recruiting

Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

for
Small Cell Carcinoma of the Bladder,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06228066

Phase2, Recruiting

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

for
Central Nervous System Neoplasms, Glioblastoma,
Location: Bethesda MD
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04541082

Phase1, Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

for
High Grade Epithelial Ovarian Cancer,
Location: Boston MA, Providence RI, Camden NJ, Doylestown PA,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT05579366

Phase1, Phase2, Recruiting

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

for
Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation,
Location: Baltimore MD, Winston-Salem NC, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18+

Code: NCT05691465

Phase2, Recruiting

A Study of CRD3874-SI in People With Solid Tumors

for
Sarcoma, Merkel Cell Carcinoma
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06021626

Phase1, Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

for
Solid Tumor, Advanced Solid Tumor, Solid Tumor, Adult,
Location: Boston MA, Hackensack NJ, Philadelphia PA, Fairfax VA,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 19+

Code: NCT06586957

Phase1, Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

for
HER2-positive Breast Cancer, Metastatic Cancer,
Location: Birmingham AL, Chicago IL, Orland Park IL, New Lenox IL,
Sponsor: QuantumLeap Healthcare Collaborative

Sex: All

Age: 18+

Code: NCT05868226

Phase1, Phase2, Recruiting